GENOMIC HEALTH INC
Healthcare · Services-Medical Laboratories · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $92.6M | $84.0M | $327.9M | $287.5M | $275.7M | $261.6M |
| Operating income | $23.9M | −$6.5M | −$15.4M | −$34.0M | −$23.6M | −$11.8M |
| Net income | −$3.8M | −$806,000 | −$13.9M | −$33.3M | — | — |
| Total assets | $334.4M | $231.6M | $201.1M | $184.6M | $185.9M | $177.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $270.2M | $188.3M | $156.1M | $139.5M | $145.5M | $145.0M |
| EPS (diluted) | $-0.11 | $-0.02 | $-0.42 | — | $-0.78 | $-0.03 |
| Shares out. | 35.3M | 34.1M | 33.0M | 32.2M | 31.2M | 30.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- 25.8%
- Net margin
- −4.1%
- Return on equity
- −1.4%
- Return on assets
- −1.1%
- Return on capital (ROCE)
- 8.7%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $7.65
- Revenue growth (YoY)
- 10.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Accruals / assets
- −24.0%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 4 good- Reported a net loss
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Fuchs Henry JDirector | Nov 8, 2019 | D | 6,878 | — |
| Parker Geoffrey M.Director | Nov 8, 2019 | Grant | 955 | — |
| Cohen Fred EDirector | Nov 8, 2019 | D | 68,165 | — |
| Flannelly Barry PDirector | Nov 8, 2019 | D | 397 | — |
| Graham Ginger LDirector | Nov 8, 2019 | D | 52,349 | — |
| Leber LauraOfficer — Chief Communication Officer | Nov 8, 2019 | D | 4,352 | $0.00 |
| Mceachron KimOfficer — Chief People Officer | Nov 8, 2019 | D | 25,293 | $0.00 |
| Hoof TorstenOfficer — Chief Int'l Commercial Officer | Nov 8, 2019 | D | 4,479 | $0.00 |
| Radford Jason W.Officer — Chief Legal Officer | Nov 8, 2019 | D | 8,384 | $0.00 |
| Vaughn James JOfficer — Chief Commercial Officer | Nov 8, 2019 | D | 5,249 | $0.00 |
| Pla FredericOfficer — COO | Nov 8, 2019 | D | 18,510 | $0.00 |
| Shak StevenOfficer — Chief Scientific Officer | Nov 8, 2019 | D | 49,585 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 8, 2019
- Shareholder vote · Regulation FD disclosureNov 7, 2019
- Other material eventOct 28, 2019
- Other material eventSep 11, 2019
- Entered a material agreementJul 30, 2019
- Other material eventJul 29, 2019
- Results of operationsJul 29, 2019
- Shareholder voteJun 18, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 13, 2020
- 15-12GNov 18, 2019
- EFFECTNov 15, 2019
- EFFECTNov 15, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.